324 related articles for article (PubMed ID: 27814748)
1. Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis.
Verhoeven F; Prati C; Maguin-Gaté K; Wendling D; Demougeot C
Arthritis Res Ther; 2016 Nov; 18(1):258. PubMed ID: 27814748
[TBL] [Abstract][Full Text] [Related]
2. Microvascular endothelial dysfunction in rheumatoid arthritis.
Bordy R; Totoson P; Prati C; Marie C; Wendling D; Demougeot C
Nat Rev Rheumatol; 2018 Jul; 14(7):404-420. PubMed ID: 29855620
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies.
Totoson P; Maguin-Gaté K; Prati C; Wendling D; Demougeot C
Arthritis Res Ther; 2014 Jan; 16(1):202. PubMed ID: 24457026
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis.
Verhoeven F; Totoson P; Maguin-Gaté K; Prigent-Tessier A; Marie C; Wendling D; Moretto J; Prati C; Demougeot C
Clin Exp Immunol; 2017 May; 188(2):208-218. PubMed ID: 28152574
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Garcia-Porrua C; Llorca J; Martin J
Biomed Pharmacother; 2006 Dec; 60(10):673-7. PubMed ID: 17049201
[TBL] [Abstract][Full Text] [Related]
6. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F
J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucocorticoids on the arteries in rheumatoid arthritis.
del Rincón I; O'Leary DH; Haas RW; Escalante A
Arthritis Rheum; 2004 Dec; 50(12):3813-22. PubMed ID: 15593231
[TBL] [Abstract][Full Text] [Related]
8. Predictors of endothelial dysfunction and atherosclerosis in rheumatoid arthritis in Indian population.
Verma I; Syngle A; Krishan P
Indian Heart J; 2017; 69(2):200-206. PubMed ID: 28460767
[TBL] [Abstract][Full Text] [Related]
9. Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
Toussirot É
Expert Opin Drug Saf; 2015 Apr; 14(4):525-32. PubMed ID: 25599626
[TBL] [Abstract][Full Text] [Related]
10. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
11. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
Kerola AM; Kauppi MJ; Kerola T; Nieminen TV
Ann Rheum Dis; 2012 Oct; 71(10):1606-15. PubMed ID: 22736093
[TBL] [Abstract][Full Text] [Related]
12. Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
J Rheumatol; 2012 Jul; 39(7):1341-7. PubMed ID: 22660798
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts.
Avagimyan A; Fogacci F; Pogosova N; Kakturskiy L; Jndoyan Z; Faggiano A; Bairamyan T; Agati L; Sattar Y; Mkrchyan L; Avetisyan G; Ginosyan K; Aznauryan A; Sahakyan K; Trofimenko A; Urazova O; Mikhaleva L; Vandysheva R; Kogan E; Demura T; Kc M; Shafie D; Nicola S; Brussino L; Cicero A; Biondi-Zoccai G; Sarrafzadegan N
Curr Probl Cardiol; 2024 Feb; 49(2):102230. PubMed ID: 38040221
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis.
González-Gay MA; González-Juanatey C
Arthritis Res Ther; 2012 Jul; 14(4):122. PubMed ID: 22808986
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
López-Mejías R; Corrales A; Genre F; Hernández JL; Ochoa R; Blanco R; González-Juanatey C; Martín J; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2013; 31(5):761-6. PubMed ID: 23899926
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis: a disease associated with accelerated atherogenesis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Martin J
Semin Arthritis Rheum; 2005 Aug; 35(1):8-17. PubMed ID: 16084219
[TBL] [Abstract][Full Text] [Related]
17. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
Pieringer H; Pichler M; Pohanka E; Hoppe UC
Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
[TBL] [Abstract][Full Text] [Related]
18. Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"?
Fietta P; Delsante G
Acta Biomed; 2009; 80(3):177-86. PubMed ID: 20578409
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
20. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.
So H; Lam TO; Meng H; Lam SHM; Tam LS
Ann Rheum Dis; 2023 Nov; 82(11):1387-1393. PubMed ID: 37487608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
